PROTAC Library

Loading...
E3 Ligase
Target
Molecular Weight
to
Your selection
  • Your selection
Structure Catalog Product Name CAS E3 Ligase Target Inquiry
A012 BPL-201693 A012 2756586-50-0

CRBN

AR

Inquiry

Molecular Weight: 780.29

Molecular Formula: C40H42ClN9O6

Density: 1.49±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A013 BPL-201694 A013 2756586-51-1

CRBN

AR

Inquiry

Molecular Weight: 766.26

Molecular Formula: C39H40ClN9O6

Density: 1.51±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A014 BPL-201695 A014 2756586-52-2

CRBN

AR

Inquiry

Molecular Weight: 822.37

Molecular Formula: C43H48ClN9O6

Density: 1.43±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A015 BPL-201696 A015 2756586-53-3

CRBN

AR

Inquiry

Molecular Weight: 813.36

Molecular Formula: C46H45ClN6O6

Density: 1.45±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A016 BPL-201697 A016 2756586-54-4

CRBN

AR

Inquiry

Molecular Weight: 876.48

Molecular Formula: C49H58ClN7O6

Boiling Point: 1035.0±65.0°C at 760 Torr

Density: 1.34±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A017 BPL-201698 A017 2756586-55-5

CRBN

AR

Inquiry

Molecular Weight: 890.53

Molecular Formula: C50H60ClN7O6

Boiling Point: 1030.3±65.0°C at 760 Torr

Density: 1.33±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A018 BPL-201699 A018 2756586-56-6

CRBN

AR

Inquiry

Molecular Weight: 834.42

Molecular Formula: C46H52ClN7O6

Boiling Point: 1022.1±65.0°C at 760 Torr

Density: 1.38±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A019 BPL-201700 A019 2756586-57-7

CRBN

AR

Inquiry

Molecular Weight: 848.45

Molecular Formula: C47H54ClN7O6

Boiling Point: 1026.2±65.0°C at 760 Torr

Density: 1.37±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A020 BPL-201701 A020 2756586-58-8

CRBN

AR

Inquiry

Molecular Weight: 862.47

Molecular Formula: C48H56ClN7O6

Boiling Point: 1030.6±65.0°C at 760 Torr

Density: 1.35±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A021 BPL-201702 A021 2756586-59-9

VHL

AR

Inquiry

Molecular Weight: 1148.89

Molecular Formula: C62H79ClFN9O7S

Density: 1.33±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A022 BPL-201703 A022 2756586-60-2

VHL

AR

Inquiry

Molecular Weight: 1134.86

Molecular Formula: C61H77ClFN9O7S

Density: 1.34±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A023 BPL-201704 A023 2756586-61-3

VHL

AR

Inquiry

Molecular Weight: 1120.83

Molecular Formula: C60H75ClFN9O7S

Density: 1.35±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A024 BPL-201705 A024 2682255-35-0

VHL

AR

Inquiry

Molecular Weight: 965.62

Molecular Formula: C51H61ClN8O7S

Boiling Point: 1147.6±65.0°C at 760 Torr

Density: 1.37±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A025 BPL-201706 A025 2756586-62-4

VHL

AR

Inquiry

Molecular Weight: 921.57

Molecular Formula: C49H57ClN8O6S

Boiling Point: 1133.4±65.0°C at 760 Torr

Density: 1.38±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A026 BPL-201707 A026 2756586-63-5

VHL

AR

Inquiry

Molecular Weight: 935.59

Molecular Formula: C50H59ClN8O6S

Boiling Point: 1145.4±65.0°C at 760 Torr

Density: 1.37±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A027 BPL-201708 A027 2682255-92-9

VHL

AR

Inquiry

Molecular Weight: 981.62

Molecular Formula: C50H61ClN10O7S

Boiling Point: 1186.0±65.0°C at 760 Torr

Density: 1.39±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A028 BPL-201709 A028 2682255-37-2

VHL

AR

Inquiry

Molecular Weight: 979.65

Molecular Formula: C52H63ClN8O7S

Boiling Point: 1144.3±65.0°C at 760 Torr

Density: 1.36±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A029 BPL-201710 A029 2682255-42-9

VHL

AR

Inquiry

Molecular Weight: 980.63

Molecular Formula: C51H62ClN9O7S

Boiling Point: 1156.7±65.0°C at 760 Torr

Density: 1.38±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A030 BPL-201711 A030 2682255-47-4

VHL

AR

Inquiry

Molecular Weight: 981.62

Molecular Formula: C50H61ClN10O7S

Boiling Point: 1161.7±65.0°C at 760 Torr

Density: 1.39±0.1 g/cm3

Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

A031 BPL-201712 A031 2682255-44-1

VHL

AR

Inquiry

Molecular Weight: 981.62

Molecular Formula: C50H61ClN10O7S

Density: 1.39±0.1 g/cm3

Description: A031 is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Inquiry Basket